Symptom Management. Thomas McKain, MD, ABFM, ABHPM Medical Director

Size: px
Start display at page:

Download "Symptom Management. Thomas McKain, MD, ABFM, ABHPM Medical Director"

Transcription

1 Symptom Management Nausea & Vomiting Thomas McKain, MD, ABFM, ABHPM Medical Director

2 Mr. Jones has nausea and vomiting. May I initiate Compazine from the Comfort Pak?

3 Objectives 1. Delineate the Differential Diagnosis for Nausea and Vomiting 2. Describe the Pathophysiology of Nausea and Vomiting 3. Explore the Pharmacologic treatment for Nausea and Vomiting

4 QUESTIONS GOING THROUGH MY MIND: Are there signs of bowel obstruction? Bowel function? Did nausea begin with a new med, such as morphine? Recent chemo or XRT? Anticipatory nausea? Is there early satiety?

5 QUESTIONS GOING THROUGH MY MIND: Is there vomiting? What is produced? Is nausea positional? Associated with anxiety? What works? What doesn't? Brain tumor? (early morning symptoms) Organ system failure?

6 OBSTRUCTED

7 HOW DO WE DIAGNOSE GI OBSTRUCTION? Check the records/ask the patient Do a CT scan, or GI series Examine the Patient!!

8 HIGH OBSTRUCTION (ESOPHAGUS) Abdomen may be flat, and benign on exam Vomiting of undigested food, which "won't go down"

9 GASTRIC OUTLET OBSTRUCTION Cancer of stomach, duodenum, head of pancreas External pressure on stomach from other tumors Food goes down, but won't stay down Food may be partially digested Abdominal exam benign, or perhaps upper mass noted

10 SMALL BOWEL OBSTRUCTION Large volume emesis, colored fluid Distended abdomen, firm, tinkling or absent bowel sounds (Fluids are normally secreted by the stomach and SB, and reabsorbed by the colon.)

11 SMALL BOWEL OBSTRUCTION

12 LOWER COLON OR RECTAL OBSTRUCTION See anorexia, and "constipation" Caused by mass in lower colon, or pelvis (must suspect!) Presents with sudden vomiting of feces Often fatal aspiration Abdomen exam NOT like SBO Rectum probably empty

13 TREATMENT OF BOWEL OBSTRUCTION Decadron, opioid, haldol, IVF Add Robinul and/or Octreotide Surgery: PEG for drainage; colostomy; remove obstruction

14 NON-OBSTRUCTED N/V

15 METABOLIC (toxins, inflammation, etc.) liver, renal failure, cancer Infections low sodium; high calcium

16 MEDS CHEMO XRT OPIOIDS

17 INTRACRANIAL PRESSURE, HEADACHES, VERTIGO

18 CONSTIPATION

19 HOW OPIOIDS CAUSE CONSTIPATION Decrease peristalsis Increase sphincter tone Decrease fluid secretion into bowel Increase fluid reabsorption from bowel

20 ULCERS, GB DISEASE, PANCREATITIS, ETC.

21 GASTROPARESIS (see early satiety) Diabetes, Autonomic dysfunction, Alcoholism, Parkinson's, Chemo, XRT, Drugs (opioids, etc.) Treat with Reglan (lower dose in CKD), Erythromycin, Prilosec, Zantac, et al.

22 TREATMENT OF NAUSEA Assess the cause, and the chemistry involved May need more than one anti-emetic, and may need to be scheduled

23 ANATOMY/PHYSIOLOGY Chemoreceptor Trigger Zone (CTZ): floor of 4th ventricle of brain Vomiting Center (VC): medulla (brainstem)

24 ANATOMY/PHYSIOLOGY

25 ANATOMY/PHYSIOLOGY

26 CHEMICAL MEDIATORS AND (RECEPTORS) Serotonin (5HT3) Dopamine (D2) Acetylcholine (Ach-m) Histamine (H1)

27 MEDICATIONS AND CHEMISTRY INVOLVED

28 SEROTONIN (5HT3) Zofran (ondansetron), et al Remeron (mirtazapine) Reglan (metoclopramide) (high doses)

29 DOPAMINE (D2) Reglan (metoclopramide) Haldol (haloperidol) Compazine (prochlorperazine) Thorazine (chlorpromazine)

30 ACETYLCHOLINE (Ach-m) Phenergan (promethazine) Antivert (meclizine) Benadryl (diphenhydramine) Levsin (hyoscyamine) Robinul (glycopyrrolate) Transderm Scop (scopolamine)

31 HISTAMINE (H1) Phenergan (promethazine) Antivert (meclizine) Benadryl (diphenhydramine) Atarax (hydroxyzine)

32 OPIOID-INDUCED NAUSEA (may resolve with time) Effects on gut (gastroparesis), CTZ, and vestibular system Can try lower dose of opioid, or rotate to another Could try Reglan, Zofran, and meclizine

33 CHEMO-INDUCED NAUSEA Need 3 drugs: -Zofran -Decadron -Emend (aprepitant) Alternatives to Zofran: -Kytril (granisetron) -Anzemet (dolasetron)

34 GASTROINTESTINAL IRRITATION/DISEASE All mediators may be involved, so multiple meds may be needed Steroids, Reglan, Zofran, meclizine, Ativan

35 VESTIBULAR NAUSEA (Positional) Histamine and Acetylcholine Opioids may be the cause meclizine, or Phenergan, or Benadryl

36 ANXIETY "Waves of nausea" Use Benzodiazepines (Also for anticipatory nausea)

37 EMPIRICAL APPROACH 1. Reglan...to block dopamine, and promote gastric motility 2. Try Haldol, OR, Compazine, OR Thorazine 3. Try Phenergan, OR, meclizine 4. Zofran

38 REGLAN AS FIRST LINE Use lower doses in CKD Avoid in pts with seizure disorders Avoid in pts with abdominal pain Can cause dystonias, akathisia, etc.

39 RESISTANT CASES Zyprexa/olanzapine, 2.5 to 5 mg qhs, as single agent Non-formulary, needs override Zyprexa can antagonize all 4 receptors: dopamine, serotonin, acetylcholine, and histamine Can improve appetite, mood, sleep

40 QUESTIONS?

Nausea. Assessment & Management. R J Crossno, MD, CMD, FAAFP, FAAHPM. Disclosures

Nausea. Assessment & Management. R J Crossno, MD, CMD, FAAFP, FAAHPM. Disclosures Nausea Assessment & Management R J Crossno, MD, CMD, FAAFP, FAAHPM Disclosures Dr. Crossno discloses his employment as Area Medical Director for VistaCare VistaCare has provided commercial support for

More information

Nausea and Vomiting in Palliative Care

Nausea and Vomiting in Palliative Care Nausea and Vomiting in Palliative Care Definitions Nausea - an unpleasant feeling of the need to vomit Vomiting - the expulsion of gastric contents through the mouth, caused by forceful and sustained contraction

More information

DECONTAMINATION AGENTS and ANTIEMETICS *** This material won t be covered in lecture, but you are responsible for it***

DECONTAMINATION AGENTS and ANTIEMETICS *** This material won t be covered in lecture, but you are responsible for it*** Decontamination and Antiemetics Med 5724 Page 1 of 8 DECONTAMINATION AGENTS and ANTIEMETICS *** This material won t be covered in lecture, but you are responsible for it*** REFERENCES: Katzung (9th ed.)

More information

9/20/2017. Effectively Managing Nausea and Vomiting. Disclosure. Objectives

9/20/2017. Effectively Managing Nausea and Vomiting. Disclosure. Objectives Effectively Managing Nausea and Myra Belgeri, Pharm.D, BCGP, BCPS, FASCP Clinical Pharmacist, Optum Hospice Pharmacy Services October 2017 1 Disclosure I have no relevant financial relationships with manufacturers

More information

Five Centers of Nausea. Linda Tavel, MD Program Medical Director VistaCare Hospice

Five Centers of Nausea. Linda Tavel, MD Program Medical Director VistaCare Hospice Five Centers of Nausea Linda Tavel, MD Program Medical Director VistaCare Hospice Objectives Prevalence of nausea and vomiting Anatomic and physiologic paths to nausea Evaluation of nausea Treatment of

More information

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics Dr. Alia Shatanawi 11-04-2018 Drugs used in Irritable Bowel Syndrome Idiopathic, chronic, relapsing disorder characterized by abdominal discomfort

More information

First a caution. Processes we might NOT try to treat with medications. Processes we might try to treat. Main drug categories.

First a caution. Processes we might NOT try to treat with medications. Processes we might try to treat. Main drug categories. Pharmacological Interventions for dizziness Timothy C. Hain, MD Northwestern University Medical School Chicago, Illinois, USA First a caution Torok N. Old and new in Meniere's disease. Laryngoscope 87:1870-1877,

More information

If we are going to treat this, of course it's like most things, we want to treat the underlying cause as well as the effect.

If we are going to treat this, of course it's like most things, we want to treat the underlying cause as well as the effect. Systemic Management of Nausea: Antiemetics Bruce Flint O.D. Antiemetics: This is for controlling nausea and vomiting. These are multiple conditions that's causing this. It's kind of common. I'm sure all

More information

First a caution. Processes we might NOT try to treat with medications. Processes we might try to treat. Main drug categories.

First a caution. Processes we might NOT try to treat with medications. Processes we might try to treat. Main drug categories. Pharmacological Interventions for dizziness Timothy C. Hain, MD Northwestern University Medical School Chicago, Illinois, USA First a caution Torok N. Old and new in Meniere's disease. Laryngoscope 87:1870-1877,

More information

Generic (Brand) Strength & Dosage form Fml Limit Cost per Rx Notes 5-HT3 Antagonists

Generic (Brand) Strength & Dosage form Fml Limit Cost per Rx Notes 5-HT3 Antagonists MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Nausea LAST REVIEW 9/11/2018 THERAPEUTIC CLASS Gastrointestinal Disorders REVIEW HISTORY 12/16, 11/15, 11/07 LOB AFFECTED

More information

Disclosures 9/17/2018. Best Practices in the Treatment of Nausea and Vomiting

Disclosures 9/17/2018. Best Practices in the Treatment of Nausea and Vomiting Best Practices in the Treatment of Nausea and Vomiting Jennifer Gabbard, MD Wake Forest School of Medicine jgabbard@wakehealth.edu 42 nd Annual Hospice & Palliative Care Conference September 2018 Charlotte,

More information

Pharmacology. Drugs that Affect the Gastrointestinal System

Pharmacology. Drugs that Affect the Gastrointestinal System Pharmacology Drugs that Affect the Gastrointestinal System Topics Peptic Ulcer Disease Constipation Diarrhea Emesis Digestion Peptic Ulcer Disease Factors that Increase Acidity Factors that Protect Against

More information

Approach to Nausea & Vomi2ng

Approach to Nausea & Vomi2ng Approach to Nausea & Vomi2ng Med 3 Seminar 2017 Dr. Robin Grant Division of Pallia2ve Medicine robin.grant@nshealth.ca Why nausea and vomi2ng? Pain 80-90+ % Fa2gue / asthenia 75-90% Cons2pa2on 70% Dyspnea

More information

A SLP s Guide to Medication Therapy and Management. Sarah Luby, PharmD, BCPS KSHA 2017

A SLP s Guide to Medication Therapy and Management. Sarah Luby, PharmD, BCPS KSHA 2017 A SLP s Guide to Medication Therapy and Management Sarah Luby, PharmD, BCPS KSHA 2017 Objectives Identify the appropriate route of administration for medications and proper formulations for use Understand

More information

Worshipping at the Porcelain Altar: Nausea and Vomiting

Worshipping at the Porcelain Altar: Nausea and Vomiting Worshipping at the Porcelain Altar: Nausea and Vomiting EDUARDO GODOY, MD FAMILY MEDICINE, SOUTH BAY MEDICAL CENTER TORRANCE MOB Financial Disclosures: I have no financial ties other than those owed: to

More information

Vomiting Approach to diagnosis

Vomiting Approach to diagnosis Vomiting Approach to diagnosis By Dr. Sahar El-Gharabawy Associate professor of internal medicine Hepato-gastroenterology Unit )SMH ) Mansoura University Definitions: Nausea: Feeling "sick to the stomach",

More information

Prevention of Antineoplastic Medication induced Nausea and Vomiting in Pediatric Cancer Patients

Prevention of Antineoplastic Medication induced Nausea and Vomiting in Pediatric Cancer Patients Prevention of Antineoplastic Medication induced Nausea and Vomiting in Pediatric Cancer Patients Done by :Meznah Zaid Al-Mutairi Pharm.D Candidate PNU University College of Pharmacy Introduction Nausea

More information

Chapter 29 - Nausea and Vomiting

Chapter 29 - Nausea and Vomiting Chapter 29 - Nausea and Vomiting Episode Overview: 1) Describe the mechanism of development of a Hypochloremic Metabolic Alkalosis in vomiting 2) List commonly used anti-emetics including their dose and

More information

Neuro Basics SLO Practice (online) Page 1 of 5

Neuro Basics SLO Practice (online) Page 1 of 5 Neuro Basics SLO Practice (online) Page 1 of 5 1) Biogenic amines include ACh, NE, EPI and? a) Melatonin b) Dopamine c) Serotonin d) Histamine e) All of the neurotransmitters listed are biogenic amines.

More information

Somatostatin analogues. Other drugs

Somatostatin analogues. Other drugs Octreotide Somatostatin analogues Lack the adverse effects of antimuscarinic agents Somatostatin decreases the release of gastrin, insulin, glucagon, gastric acid and pancreatic enzymes Also inhibits neurotransmission

More information

Nausea & Vomiting. Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA

Nausea & Vomiting. Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA Nausea & Vomiting Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA Prevalence prevalence varies *, systemic review 2007 : overall prevalence : nausea 30%, vomiting 20% in last 1-2 weeks of life : nausea

More information

CYCLIC VOMITING SYNDROME. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis

CYCLIC VOMITING SYNDROME. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis CYCLIC VOMITING SYNDROME C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis Case 26 year old male Symptoms began at age 19 yr 5-6 day episodes of recurrent, severe vomiting

More information

Management of Postoperative Nausea and Vomiting in Ambulatory Surgery The Big Little Problem

Management of Postoperative Nausea and Vomiting in Ambulatory Surgery The Big Little Problem Management of Postoperative Nausea and Vomiting in Ambulatory Surgery The Big Little Problem Mary Keyes, MD KEYWORDS Postoperative nausea and vomiting PONV prophylaxis PONV in ambulatory surgery KEY POINTS

More information

Agitation Excessive physical or mental restlessness. Increased activity that is generally not purposeful and associated with anxiety.

Agitation Excessive physical or mental restlessness. Increased activity that is generally not purposeful and associated with anxiety. October 2012 4 Agitation Excessive physical or mental restlessness. Increased activity that is generally not purposeful and associated with anxiety. Depending on appropriateness, evaluate for reversible

More information

Delirium and Nausea. Delirium - definition. Delirium Incidence. Predisposing Risk Factors for Delirium. Impact. Delirium Types 10/14/2016

Delirium and Nausea. Delirium - definition. Delirium Incidence. Predisposing Risk Factors for Delirium. Impact. Delirium Types 10/14/2016 Delirium - definition Delirium and Nausea Etiologically non-specific global cerebral dysfunction associated with changes in LOC, attention, thinking, perception, memory, psychomotor behavior, emotion and

More information

Managing Adverse Events in the Cancer Patient. Learning Objectives. Chemotherapy-Induced Nausea/Vomiting

Managing Adverse Events in the Cancer Patient. Learning Objectives. Chemotherapy-Induced Nausea/Vomiting Managing Adverse Events in the Cancer Patient Lisa A Thompson, PharmD, BCOP Assistant Professor University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Learning Objectives Describe

More information

Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment

Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment CONSTIPATION Constipation An Overview Definition Physiology of GI tract Etiology Assessment Treatment Definition Constipation = the infrequent passage of hard feces Definition of Infrequent The meaning

More information

ATTUALITÀ NEL CONTROLLO DELL EMESI

ATTUALITÀ NEL CONTROLLO DELL EMESI ATTUALITÀ NEL CONTROLLO DELL EMESI Dr Claudio Lotesoriere Dipartimento di Oncoematologia S.C. di Oncologia Medica P.O. San G. Moscati TARANTO email oncologia.taranto@gmail.com Types of CINV: Definitions

More information

Zofran for motion sickness

Zofran for motion sickness Zofran for motion sickness The star of the motion sickness natural remedies line up has to be ginger! Although it doesn't work for everyone, lots of people find it very effective indeed. 4-3-2018 What

More information

Propulsion and mixing of food in the alimentary tract Chapter 63

Propulsion and mixing of food in the alimentary tract Chapter 63 Propulsion and mixing of food in the alimentary tract Chapter 63 Types of GI movements: Propulsive movement-peristalsis Propulsion: controlled movement of ingested foods, liquids, GI secretions, and sloughed

More information

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information OHSU PARKINS ON CENTER Parkinson s Disease: Diagnosis and Management for Every MD Disclosure Information Grants/Research Support: National Parkinson Foundation, NIH, Michael J. Fox Foundation Consultant:

More information

From Heave to Leave: Understanding Cyclic Vomiting Syndrome in the Adult Population

From Heave to Leave: Understanding Cyclic Vomiting Syndrome in the Adult Population From Heave to Leave: Understanding Cyclic Vomiting Syndrome in the Adult Population Andrea H. Thurler, DNP, FNP-BC Stephanie M. Doherty, MSN, AGNP-BC In collaboration with Dr. Braden Kuo, MD and Dr. Kyle

More information

Our evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders.

Our evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders. Our evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders. SmartPill benefits your practice: Convenient performed right in your office Test standardization Provides direct

More information

Advanced Symptom Management

Advanced Symptom Management Advanced Symptom Management Janet Bull, MD, FAAHPM Four Seasons Symptom Management o Objectives Define symptom clusters and the role of cytokines Identify different clusters and treatment options Describe

More information

Burt. Symptom Management 11/7/2016. Always looking for lowest dose to achieve symptom management to limit side effects

Burt. Symptom Management 11/7/2016. Always looking for lowest dose to achieve symptom management to limit side effects Francine Arneson, MD Palliative Medicine Medical Director Burt 72 year old male with a history of DM, HTN, and CKD Creatinine 2.1 baseline History of smoking Presented with cough, severe back pain Workup

More information

LESSON ASSIGNMENT. Emetics, Antiemetics, and Antidiarrheals. After completing this lesson, you should be able to:

LESSON ASSIGNMENT. Emetics, Antiemetics, and Antidiarrheals. After completing this lesson, you should be able to: LESSON ASSIGNMENT LESSON 3 Emetics, Antiemetics, and Antidiarrheals. LESSON ASSIGNMENT Paragraphs 3-1 through 3-8. LESSON OBJECTIVES After completing this lesson, you should be able to: 3-1. Given one

More information

Methods to Reduce and Treat Opioid Induced Adverse Events. Raymond Sinatra, MD, PhD

Methods to Reduce and Treat Opioid Induced Adverse Events. Raymond Sinatra, MD, PhD Methods to Reduce and Treat Opioid Induced Adverse Events Raymond Sinatra, MD, PhD Opioid Analgesics Annoying Side Effects Life Threatening Side Effects Improved Pain Control Opioid Induced Adverse Events

More information

Pediatric Pharmacotherapy 101: Gastrointestinal Symptom Management

Pediatric Pharmacotherapy 101: Gastrointestinal Symptom Management Pediatric Pharmacotherapy 101: Gastrointestinal Symptom Management Melissa Hunt, PharmD Pediatric Clinical Pharmacist Optum Hospice Pharmacy Services Cortney Rogers, PharmD, BCPPS Clinical Pharmacy Supervisor

More information

Second term/

Second term/ Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic

More information

Page 1 of 6 PATIENT PRESENTATION PROPHYLAXIS. No risk factors from the categories

Page 1 of 6 PATIENT PRESENTATION PROPHYLAXIS. No risk factors from the categories Page 1 of 6 PATIENT PRESENTATION PROPHYLAXIS risk factors from the categories listed below more than one drug prophylaxis (see Appendix A for antiemetic choices) Patient scheduled for surgery Assess patient

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Cesamet) Reference Number: CP.PMN.160 Effective Date: 11.16.16 Last Review Date: 02.19 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

Part 2: Pain and Symptom Management Nausea and Vomiting

Part 2: Pain and Symptom Management Nausea and Vomiting Part 2: Pain and Symptom Management Nausea and Vomiting Effective Date: February 22, 2017 Key Recommendations Select anti-nausea medication based on the etiology of the nausea and vomiting. Assessment

More information

Amyloidosis & the GI Tract

Amyloidosis & the GI Tract Amyloidosis & the GI Tract John O. Clarke, M.D. Director, Esophageal Program Clinical Associate Professor of Medicine Stanford University john.clarke@stanford.edu 2017 Topics to cover 1) Patterns of GI

More information

AUTACOIDS. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan April, 2014

AUTACOIDS. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan April, 2014 AUTACOIDS Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan April, 2014 AUTACOIDS Endogenous substances with complex physiologic and pathphysiologic functions; commonly understood

More information

Updates in Chemotherapy-Induced Nausea and Vomiting (CINV) 2017

Updates in Chemotherapy-Induced Nausea and Vomiting (CINV) 2017 Updates in Chemotherapy-Induced Nausea and Vomiting (CINV) 2017 MELISSA C. MACKEY, PHARMD, BCPS, BCOP ONCOLOGY CLINICAL PHARMACIST DUKE UNIVERSITY HOSPITAL AUGUST 5, 2017 Objectives Review risk factors

More information

Clinical Policy: Nabilone (Cesamet) Reference Number: ERX.NPA.35 Effective Date:

Clinical Policy: Nabilone (Cesamet) Reference Number: ERX.NPA.35 Effective Date: Clinical Policy: (Cesamet) Reference Number: ERX.NPA.35 Effective Date: 09.01.17 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in Anesthesia and Neurology Harvard Medical School Limited time

More information

GASTROPARESIS 101: BEGINNERS GUIDE TO UNDERSTANDING GASTROPARESIS By: Dr. Josh Ferguson 2017

GASTROPARESIS 101: BEGINNERS GUIDE TO UNDERSTANDING GASTROPARESIS By: Dr. Josh Ferguson 2017 GASTROPARESIS 101: BEGINNERS GUIDE TO UNDERSTANDING GASTROPARESIS By: Dr. Josh Ferguson 2017 This tough looking word, pronounced gas-tro-par-ees-is, is simple enough in its meaning. Gastro means stomach.

More information

Nausea and Vomiting. Principles and Practice in End of Life Care November 2018

Nausea and Vomiting. Principles and Practice in End of Life Care November 2018 Nausea and Vomiting Principles and Practice in End of Life Care November 2018 Overview Aims and Objectives Why is managing nausea and vomiting important? Definitions Causes Interventions pharmacological

More information

SAEMS. Ondansetron HCL Self-Learning Module

SAEMS. Ondansetron HCL Self-Learning Module SAEMS Ondansetron HCL Self-Learning Module Dawn Daniels Tucson Medical Center November, 2008 1 DATE: November 2008 PURPOSE TRAINING MODULE FOR ONDANSETRON This Training Module has been developed to serve

More information

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Erin Zimny, MD Emergency Medicine Hospice and Palliative Medicine Henry Ford Hospital Disclosures I do NOT have any financial

More information

9/26/2018. Cost-Effective Symptom Management HOSPICE. Serious/Chronic Illnesses. Hospice Care. Presentation Objectives

9/26/2018. Cost-Effective Symptom Management HOSPICE. Serious/Chronic Illnesses. Hospice Care. Presentation Objectives Cost-Effective Symptom Management Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Define Define Hospice Care Presentation Objectives Determine Determine Common Hospice Diagnoses Review

More information

Evaluation of Three 5-HT 3

Evaluation of Three 5-HT 3 Evaluation of Three Receptor Antagonists in the Prevention of Postoperative Nausea and Vomiting in Adults Shan Wang, PharmD, Joseph Greco, MD, Reena A. Joseph, PharmD Candidate, Martin Feuerman, MS, and

More information

VOMITING. Tan Lay Zye

VOMITING. Tan Lay Zye VOMITING Tan Lay Zye Vomiting is a common symptom. It is a complex reflex behavioural response involving forceful expulsion of the stomach contents through oral cavity. Contents Emetic reflex Causes of

More information

Disclosures. Objectives. Gastroparesis: Are We Moving On? Gastroparesis: Clinical Overview

Disclosures. Objectives. Gastroparesis: Are We Moving On? Gastroparesis: Clinical Overview Gastroparesis: Are We Moving On? Anthony Lembo, M.D. Associate Professor of Medicine Harvard Medical School Beth Israel Deaconess Medical Center Boston, MA Disclosures Consultant Alkermes, Allergan, Forest,

More information

Gastroparesis and other upper GI problems DR ANDREW DAVIES

Gastroparesis and other upper GI problems DR ANDREW DAVIES Gastroparesis and other upper GI problems DR ANDREW DAVIES Outline Gastroparesis Hiccoughs Gastroparesis Gastroparesis Definition: A syndrome of objectively delayed gastric emptying in the absence of mechanical

More information

Clinical Policy: Dolasetron (Anzemet) Reference Number: ERX.NPA.83 Effective Date:

Clinical Policy: Dolasetron (Anzemet) Reference Number: ERX.NPA.83 Effective Date: Clinical Policy: (Anzemet) Reference Number: ERX.NPA.83 Effective Date: 09.01.18 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Controlling nausea and vomiting: anti-emetic therapy advice

Controlling nausea and vomiting: anti-emetic therapy advice Controlling nausea and vomiting: anti-emetic therapy advice Chemotherapy A guide for patients and carers Contents Treatments that may cause nausea and vomiting... 2 Physical reasons that may cause nausea

More information

Inpatient Palliative Medicine Update

Inpatient Palliative Medicine Update Inpatient Palliative Medicine Update David Dupere MD, FRCPC Head, Division of Palliative Medicine Department of Medicine QEII Health Sciences Centre Halifax, Nova Scotia Disclosures Book chapter in Compendium

More information

Management of Chemotherapy Induced Nausea/Vomiting(CINV) in Adult Cancer Patients

Management of Chemotherapy Induced Nausea/Vomiting(CINV) in Adult Cancer Patients Management of Chemotherapy Induced Nausea/Vomiting(CINV) in Adult Cancer Patients By Zahra Shaghaghi, Pharm-D, BCOP, PhC Prepared for 2018 NMSHP Balloon Fiesta Symposium Goals and Objectives: Describe

More information

Management of Chemotherapy Induced Nausea/Vomiting(CINV) in Adult Cancer Patients

Management of Chemotherapy Induced Nausea/Vomiting(CINV) in Adult Cancer Patients Management of Chemotherapy Induced Nausea/Vomiting(CINV) in Adult Cancer Patients By Zahra Shaghaghi, Pharm-D, BCOP, PhC Prepared for 2018 NMSHP Balloon Fiesta Symposium 1 Goals and Objectives: Describe

More information

Gastrointestinal obstruction Dr Iain Lawrie

Gastrointestinal obstruction Dr Iain Lawrie Gastrointestinal obstruction Dr Iain Lawrie Consultant and Honorary Clinical Senior Lecturer in Palliative Medicine The Pennine Acute Hospitals NHS Trust / The University of Manchester iain.lawrie@pat.nhs.uk

More information

EDUCATION PRACTICE. Management of Delayed Gastric Emptying. Clinical Scenario. The Problem. Management Strategies and Supporting Evidence

EDUCATION PRACTICE. Management of Delayed Gastric Emptying. Clinical Scenario. The Problem. Management Strategies and Supporting Evidence CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:642 646 EDUCATION PRACTICE Management of Delayed Gastric Emptying FRANK K. FRIEDENBERG and HENRY P. PARKMAN Temple University Hospital, Philadelphia, Pennsylvania

More information

F A M N O P R S ! D !

F A M N O P R S ! D ! A B C D E F A M N O P Q G H I J R S T U V 595 W http://www.encognitive.com/images/digestive-system-2.jpg K L M A N B C O P D E F G D Q R H S I J K http://apbrwww5.apsu.edu/thompsonj/anatomy%20&%20physiology/2020/2020%20exam%20reviews/exam%203/colon%20diagram.jpgd

More information

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. The closing date for responses is 19th December The results

More information

Focus on Upper Gastrointestinal Problems

Focus on Upper Gastrointestinal Problems Focus on Upper Gastrointestinal Problems Chapter 42, Nursing Management: Upper Gastrointestinal Problems Revised for Voice Thread Nursing 246 Gastroesophageal Reflux Disease GERD (a syndrome if with tissue

More information

Presenter Disclosure. Objectives 6/5/2017. Depression, Anxiety, PTSD: A Focus on Pharmacotherapy

Presenter Disclosure. Objectives 6/5/2017. Depression, Anxiety, PTSD: A Focus on Pharmacotherapy Depression, Anxiety, PTSD: A Focus on Pharmacotherapy Robert L Page II, Pharm.D., MSPH, FHFSA, FCCP, FAHA Professor of Clinical Pharmacy Clinical Specialist, Division of Cardiology University of Colorado

More information

A RANDOMISED, OPEN LABEL STUDY OF GUIDELINE DRIVEN TARGETED ANTIEMETIC THERAPY VERSUS SINGLE AGENT ANTIEMETIC THERAPY

A RANDOMISED, OPEN LABEL STUDY OF GUIDELINE DRIVEN TARGETED ANTIEMETIC THERAPY VERSUS SINGLE AGENT ANTIEMETIC THERAPY A RANDOMISED, OPEN LABEL STUDY OF GUIDELINE DRIVEN TARGETED ANTIEMETIC THERAPY VERSUS SINGLE AGENT ANTIEMETIC THERAPY Patsy Yates, Janet Hardy, Peter Martin, Jennifer Philip, Peter Hudson, David Currow,

More information

DOMPERIDONE BNF 4.6. Domperidone is a dopamine type 2-receptor antagonist. It is structurally related to the

DOMPERIDONE BNF 4.6. Domperidone is a dopamine type 2-receptor antagonist. It is structurally related to the DOMPERIDONE BNF 4.6 Class: Prokinetic anti-emetic. Indications: Nausea and vomiting, dysmotility dyspepsia, gastro-oesophageal reflux. Pharmacology Domperidone is a dopamine type 2-receptor antagonist.

More information

Medications used for symptom control in palliative care

Medications used for symptom control in palliative care Learning Objectives used for symptom control in palliative care Luis Viana, R. Ph., M.Ed., CGP 1. For common symptoms experienced by the person managed with palliative care: Recognize the symptom to be

More information

Lab:2 Drugs acting on Gastrointestinal tract

Lab:2 Drugs acting on Gastrointestinal tract Lab:2 Drugs acting on Gastrointestinal tract Drugs that used to treat three common medical conditions involving the gastrointestinal tract: peptic ulcers and gastroesophageal reflux disease (GERD), chemotherapy-induced

More information

3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD

3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD Psychopharmacology at the End of Life Nicole Thurston, MD Psychiatrist Mountain States Tumor Institute Objectives Describe 2 common psychiatric symptoms that can present at or near end of life. Review

More information

PONV and The Role of Therapeutic Decision Support

PONV and The Role of Therapeutic Decision Support PONV and The Role of Therapeutic Decision Support Joseph V. Pergolizzi, Jr., M.D. Adjunct Assistant Professor Johns Hopkins University Naples Anesthesia and Pain Associates Naples, Florida Editor-in Chief

More information

Gastroparesis or Cyclic Vomiting: Does it Matter for Treatment?

Gastroparesis or Cyclic Vomiting: Does it Matter for Treatment? Gastroparesis or Cyclic Vomiting: Does it Matter for Treatment? Brian E. Lacy, MD, PhD, FACG Professor of Medicine Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology & Hepatology

More information

Palliative Medicine Overview. Francine Arneson, MD Palliative Medicine

Palliative Medicine Overview. Francine Arneson, MD Palliative Medicine Palliative Medicine Overview Francine Arneson, MD Palliative Medicine Palliative Medicine: Definition Palliative care: An approach that improves the quality of life of patients and their families facing

More information

Lawrence R. Schiller, MD, FACG. Digestive Health Associates of Texas Baylor University Medical Center Dallas, Texas.

Lawrence R. Schiller, MD, FACG. Digestive Health Associates of Texas Baylor University Medical Center Dallas, Texas. Chronic Nausea & Vomiting Lawrence R. Schiller, MD, FACG Digestive Health Associates of Texas Baylor University Medical Center Dallas, Texas Nausea & Vomiting Common symptoms Quite troubling to patients

More information

Why Patients Experience Nausea and Vomiting and What to Do About It

Why Patients Experience Nausea and Vomiting and What to Do About It Why Patients Experience Nausea and Vomiting and What to Do About It Rebecca Clark-Snow, RN, BSN, OCN The University of Kansas Cancer Center Westwood, Kansas Multiple Roles for Supportive Care in Cancer

More information

Colon Cancer , The Patient Education Institute, Inc. oc Last reviewed: 05/17/2017 1

Colon Cancer , The Patient Education Institute, Inc.  oc Last reviewed: 05/17/2017 1 Colon Cancer Introduction Colon cancer is fairly common. About 1 in 15 people develop colon cancer. Colon cancer can be a life threatening condition that affects the large intestine. However, if it is

More information

Gastrointestinal motility modulating drugs include all compounds which have pharmacological

Gastrointestinal motility modulating drugs include all compounds which have pharmacological Pharmacotherapeutics Gastrointestinal Motility Modulating Drugs Oh Young Lee, MD Department of Internal Medicine, Hanyang University College of Medicine E - mail : leeoy@hanyang.ac.kr J Korean Med Assoc

More information

Vomiting IAGH monthly meeting

Vomiting IAGH monthly meeting Vomiting IAGH monthly meeting D A R V I S H M O G H A D A M K E R M A N M E D I C A L U N I V E R S I T Y 29 M E H R 1 3 8 9 Sources UpTodate 18.2 Yamada Principles of Clinical Gastroenterology 2008 Sleisenger

More information

Chapter 20 The Digestive System Exam Study Questions

Chapter 20 The Digestive System Exam Study Questions Chapter 20 The Digestive System Exam Study Questions 20.1 Overview of GI Processes 1. Describe the functions of digestive system. 2. List and define the four GI Processes: 20.2 Functional Anatomy of the

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Anzemet) Reference Number: CP.PMN.141 Effective Date: 09.01.06 Last Review Date: 08.18 Line of Business: Commercial, HIM, Medicaid Revision Log See Important Reminder at the end of this

More information

Non-Pain Symptom Management March 2012

Non-Pain Symptom Management March 2012 TXNMHO / TAPM Annual Convention March 28 2015 Ronald J Crossno, MD FAAHPM Chief Medical Officer, Kindred at Home (formerly Gentiva) ronald.crossno@gentiva.com Disclosures No relevant financial disclosures

More information

Grace Ma and Andrea Weiss FMF 2018

Grace Ma and Andrea Weiss FMF 2018 Grace Ma and Andrea Weiss FMF 2018 Presenter: Grace Ma Relationships with financial sponsors: none Presenter: Andrea Weiss Relationships with financial sponsors: none This program has not received any

More information

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

Gastroenterology. Certification Examination Blueprint. Purpose of the exam Gastroenterology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified gastroenterologist

More information

Multimodal Approach for Managing Postoperative Ileus: Role of Health- System Pharmacists (ACPE program H01P)

Multimodal Approach for Managing Postoperative Ileus: Role of Health- System Pharmacists (ACPE program H01P) 1. In the normal gastrointestinal tract, what percent of nutrient absorption occurs in the jejunum? a. 20%. b. 40%. c. 70%. d. 90%. 2. According to Dr. Erstad, the four components of gastrointestinal control

More information

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,

More information

7/13/16. Pharmaceuticals that alter GI motility. Financial disclosures. Common pharmaceuticals that alter GI Motility (an incomplete list) None

7/13/16. Pharmaceuticals that alter GI motility. Financial disclosures. Common pharmaceuticals that alter GI Motility (an incomplete list) None Pharmaceuticals that alter GI motility Megan Taylor, ND AANP 2016 Motility Bootcamp Financial disclosures None Common pharmaceuticals that alter GI Motility (an incomplete list) Analgesics Opioids NSAIDs

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Applicable Medical Benefit Effective: 6/15/18 Pharmacy- Formulary 1 x Next Review: 6/19 Pharmacy- Formulary 2 x Date of Origin: 4/99 Antiemetic Agents: Zofran /ODT (ondansetron/ondansetron

More information

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation

More information

INTRODUCTION TO GASTROINTESTINAL FUNCTIONS

INTRODUCTION TO GASTROINTESTINAL FUNCTIONS 1 INTRODUCTION TO GASTROINTESTINAL FUNCTIONS 2 Learning outcomes List two main components that make up the digestive system Describe the 6 essential functions of the GIT List factors (neurological, hormonal

More information

Opioids are useful agents for managing

Opioids are useful agents for managing Management of Common Opioid-Induced Adverse Effects JOHN M. SWEGLE, PHARM.D., Mercy Family Medicine Residency Program, Mason City, Iowa CRAIG LOGEMANN, PHARM.D., Urbandale Family Physicians, Urbandale,

More information

Management of Gastroparesis

Management of Gastroparesis Management of Gastroparesis Bible Class Jan Hendrik Niess As published in Am J Gastroenterol. 2013 Jan;108(1):18-37 What is the definition of gastroparesis? What are cardinal symptoms of gastroparesis?

More information

Drossman Gastroenterology 55 Vilcom Center Drive Boyd Hall, Suite 110 Chapel Hill, NC 27514

Drossman Gastroenterology 55 Vilcom Center Drive Boyd Hall, Suite 110 Chapel Hill, NC 27514 Drossman Gastroenterology 55 Vilcom Center Drive Boyd Hall, Suite 110 Chapel Hill, NC 27514 Normal Gastrointestinal Motility and Function "Motility" is an unfamiliar word to many people; it is used primarily

More information

Chapter 20 The Digestive System Exam Study Questions

Chapter 20 The Digestive System Exam Study Questions Chapter 20 The Digestive System Exam Study Questions 20.1 Overview of GI Processes 1. Describe the functions of digestive system. 2. List and define the four GI Processes: 20.2 Functional Anatomy of the

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available at: ALL Adult Facilities Non Categorized SUB ED Abdominal Pain Protocol(SUB)* ***The above subphase is available at the end of the plan*** SUB ED Abdominal Pain Protocol Lab

More information

SIBO

SIBO SIBO What is it? Small Intestinal Bowel Overgrowth A chronic bacterial infection of the small intestine Caused by bad bacteria such as E Coli and Clostridium migrating to the small intestine There is not

More information